Your browser doesn't support javascript.
loading
Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction.
Yufera-Sanchez, Ana; Lopez-Ayala, Pedro; Nestelberger, Thomas; Wildi, Karin; Boeddinghaus, Jasper; Koechlin, Luca; Rubini Gimenez, Maria; Sakiz, Hüseyin; Bima, Paolo; Miro, Oscar; Martín-Sánchez, F Javier; Christ, Michael; Keller, Dagmar I; Gualandro, Danielle M; Kawecki, Damian; Rentsch, Katharina; Buser, Andreas; Mueller, Christian.
Afiliación
  • Yufera-Sanchez A; Department of Cardiology, University Heart Center Basel, and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Lopez-Ayala P; GREAT Network, Basel, Switzerland.
  • Nestelberger T; Department of Cardiology, University Heart Center Basel, and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Wildi K; GREAT Network, Basel, Switzerland.
  • Boeddinghaus J; Department of Cardiology, University Heart Center Basel, and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Koechlin L; GREAT Network, Basel, Switzerland.
  • Rubini Gimenez M; Department of Cardiology, University Heart Center Basel, and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Sakiz H; GREAT Network, Basel, Switzerland.
  • Bima P; Department of Intensive Care, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Miro O; Department of Cardiology, University Heart Center Basel, and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Martín-Sánchez FJ; GREAT Network, Basel, Switzerland.
  • Christ M; Department of Cardiology, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Keller DI; Department of Cardiology, University Heart Center Basel, and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Gualandro DM; GREAT Network, Basel, Switzerland.
  • Kawecki D; Department of Cardiac Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Rentsch K; Department of Cardiology, University Heart Center Basel, and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
  • Buser A; Cardiology Department, Heart Center Leipzig, Leipzig, Germany.
  • Mueller C; Department of Cardiology, University Heart Center Basel, and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland.
Sci Rep ; 13(1): 14598, 2023 09 05.
Article en En | MEDLINE | ID: mdl-37670005
ABSTRACT
Glucose is a universally available inexpensive biomarker, which is increased as part of the physiological stress response to acute myocardial infarction (AMI) and may therefore help in its early diagnosis. To test this hypothesis, glucose, high-sensitivity cardiac troponin (hs-cTn) T, and hs-cTnI were measured in consecutive patients presenting with acute chest discomfort to the emergency department (ED) and enrolled in a large international diagnostic study (NCT00470587). Two independent cardiologists centrally adjudicated the final diagnosis using all clinical data, including serial hs-cTnT measurements, cardiac imaging and clinical follow-up. The primary diagnostic endpoint was index non-ST-segment elevation MI (NSTEMI). Prognostic endpoints were all-cause death, and cardiovascular (CV) death or future AMI, all within 730-days. Among 5639 eligible patients, NSTEMI was the adjudicated final diagnosis in 1051 (18.6%) patients. Diagnostic accuracy quantified using the area under the receiver-operating characteristics curve (AUC) for the combination of glucose with hs-cTnT and glucose with hs-cTnI was very high, but not higher versus that of hs-cTn alone (glucose/hs-cTnT 0.930 [95% CI 0.922-0.937] versus hs-cTnT 0.929 [95% CI 0.922-0.937]; glucose/hs-cTnI 0.944 [95% CI 0.937-0.951] versus hs-cTnI 0.944 [95% CI 0.937-0.951]). In early-presenters, a dual-marker strategy (glucose < 7 mmol/L and hs-cTnT < 5/hs-cTnI < 4 ng/L) provided very high and comparable sensitivity to slightly lower hs-cTn concentrations (cTnT/I < 4/3 ng/L) alone, and possibly even higher efficacy. Glucose was an independent predictor of 730-days endpoints. Our results showed that a dual marker strategy of glucose and hs-cTn did not increase the diagnostic accuracy when used continuously. However, a cutoff approach combining glucose and hs-cTn may provide diagnostic utility for patients presenting ≤ 3 h after onset of symptoms, also providing important prognostic information.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Infarto del Miocardio sin Elevación del ST / Infarto del Miocardio Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Infarto del Miocardio sin Elevación del ST / Infarto del Miocardio Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Suiza
...